Skip to main content
FinSpry Logo
FinSpry
ABVX logo
ABVX
(NASDAQ)
ABIVAX Société Anonyme
$118.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ABIVAX Société Anonyme (ABVX) Stock Price & Financial Analysis

ABIVAX Société Anonyme Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$112.00 - $119.79
52-Week High$148.83
52-Week Low$4.77
Open$112.00
Volume954.73K
Average Volume (3M)954.73K
Market Cap8.63B
Shares Outstanding72.94M
Price to Sales (P/S)480.39
Price to Book (P/B)14.22
EV/EBITDA-24.13
Revenue (TTM)17.44M
Net Income (TTM)-338.17M
Free Cash Flow (TTM)-198.26M
EPS (TTM)$-4.64
Profit Margin-1939.35%
Operating Margin-1435.12%
Return on Equity (ROE)-57.41%
Debt to Equity0.09
50-Day MA$117.72
200-Day MA$91.54
52-Week Change1851.95%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ABIVAX Société Anonyme

What is the current stock price for ABVX?

As of the latest trading session, ABVX stock trades at $118.37. The 52-week range is $4.77–$148.83, with a day range of $112.00–$119.79.

What is the P/E ratio for ABVX?

The P/E ratio (Price-to-Earnings) for ABVX is shown in the Key Statistics section. This valuation metric helps compare ABIVAX Société Anonyme to industry peers.

Does ABVX pay dividends?

ABIVAX Société Anonyme does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABVX?

Based on 9 analysts, the consensus for ABVX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABVX?

ABIVAX Société Anonyme's market capitalization is $8.63B, classifying it as a mid-cap company. ABIVAX Société Anonyme operates in the Healthcare sector within the Biotechnology industry.